Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole versus low-dose testosterone for constitutional delay of growth and puberty
2012-002477-59Phase 2Completed
- Sponsor
- Taneli Raivio
- Start
- Nov 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of letrozole and Sustanon 250 in Constitutional growth delay and delayed puberty (2 arms), sponsored by Taneli Raivio. Primary endpoints: Primary: testicular volume, Primary: urinary luteinizing hormone and 1 more. Started Nov 2012; status: completed.
02
Drugs
letrozoleSustanon 250
03
Conditions
Constitutional growth delaydelayed puberty
Beyond the preview
Go deeper on 2012-002477-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002477-59.